These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37563623)

  • 1. Optimal dose of neostigmine antagonizing cisatracurium-induced shallow neuromuscular block in elderly patients: a randomized control study.
    Cao M; Huang H; Tong J; Ou Y; Liao Y
    BMC Anesthesiol; 2023 Aug; 23(1):269. PubMed ID: 37563623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.
    Fuchs-Buder T; Baumann C; De Guis J; Guerci P; Meistelman C
    Eur J Anaesthesiol; 2013 Oct; 30(10):594-8. PubMed ID: 23803594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
    Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
    Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J; San Miguel G; García V; Pelegrín F
    Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Under sevoflurane anaesthesia, a reduced dose of neostigmine can antagonize a shallow neuromuscular block: A double-blind, randomised study.
    Preault A; Capron F; Chantereau C; Donati F; Dimet J
    Anaesth Crit Care Pain Med; 2016 Aug; 35(4):269-73. PubMed ID: 27131419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
    Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG
    Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine administration of neostigmine after recovery of spontaneous breathing versus neuromuscular monitor-guided administration of neostigmine in pediatric patients: a parallel, randomized, controlled study.
    Yang L; Hu N; Chang H; Yang D; Zuo Y
    Trials; 2023 Jan; 24(1):19. PubMed ID: 36611181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: a randomized controlled study.
    Abdulatif M; Lotfy M; Mousa M; Afifi MH; Yassen K
    Minerva Anestesiol; 2018 Aug; 84(8):929-937. PubMed ID: 29405667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcium chloride coadministered with neostigmine on neuromuscular blockade recovery: A double-blind randomised study.
    Ju JW; Kim HC; Yoon S; Hong DM; Park HP
    Eur J Anaesthesiol; 2017 Sep; 34(9):617-622. PubMed ID: 28763316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope].
    Ba YF; Liu YN; He SH; Li HM; Wang HR; Zhu JP; Xing WQ; Li CS
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):213-219. PubMed ID: 32008289
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of neostigmine on postoperative cognitive function and inflammatory factors in elderly patients - a randomized trial.
    Zhu B; Sun D; Yang L; Sun Z; Feng Y; Deng C
    BMC Geriatr; 2020 Oct; 20(1):387. PubMed ID: 33023491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
    Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O
    J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.